5 assets in Hereditary Anemia

Therapeutic assets addressing Hereditary Anemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Alemtuzumab Hereditary Anemia	Paul Szabolcs	P2	CCC (53)
Fludarabine Hereditary Anemia	Paul Szabolcs	P2	CCC (53)
Hydroxyurea Hereditary Anemia	Paul Szabolcs	P2	CCC (53)
Melphalan Hereditary Anemia	Paul Szabolcs	P2	CCC (53)
Thiotepa Hereditary Anemia	Paul Szabolcs	P2	CCC (53)